We use cookies to ensure you get the best experience on our website. Cookie Policy 
News Release

Medica Introduces Insulin Cost Relief Program

MINNETONKA, Minn. — In Medica’s continuing efforts to address the rising cost of insulin, we are introducing a cap on the maximum amount commercial and individual market members will pay for their insulin. Starting January 1, 2020, all members of fully insured commercial groups headquartered in Minnesota and individual members in Minnesota will pay no more than $25 for each 30-day supply of insulin. This enhancement will apply to all insulin covered by their plan.

This benefit improvement will not have an effect on member premiums already filed with the State of Minnesota for 2020.

"This program is just one example of how Medica works to address the pressing health care issues our members are facing," said John Naylor, Medica President and Chief Executive Officer. "It is actions like this that our members and customers have come to expect as they put their trust in us and we support them with their health care needs."

Medica has a long history of providing personalized support to members through diabetes education and care management programs that focus on preventing and managing the disease in the most effective way possible. This program will offer more affordable access to insulin, the price of which manufacturers have been increasing at an unsustainable rate. More than 30 million Americans need the life-saving drug. According to a report from a working group at the American Diabetes Association (ADA), the list price of insulin has more than doubled in the last decade.